Effects of rapamycin on active Heymann nephritis

American Journal of Nephrology

Volumn 27, Issue 4, 2007, Pages 379-389

  Naumovic, Radomir ^a   Jovovic, Djurdjica ^b   Basta Jovanovic, Gordana ^c   Miloradovic, Zoran ^b   Mihailovic Stanojevic, Nevena ^b   Aleksic, Tamara ^b   Jovanovic, Dijana ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Faculty of Medicine   (Serbia)

Author keywords

CD8+ cells; Heymann nephritis; Proteinuria; Rapamycin

Indexed keywords

RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; GLOMERULUS BASEMENT MEMBRANE; HEYMANN NEPHRITIS; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROTEINURIA; RATS; RATS, WISTAR; SIROLIMUS;

EID: 34447564166     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103918     Document Type: Article

References (31)

1. Heymann V, Hackel DB, Harwood S, et al: Production of nephrotic syndrome in rats by Freund's adjuvant and rat kidney suspension. Proc Exp Biol Med 1959;100:660-664.
2. Couser WG, Abrass CK: Pathogenesis of membranous nephropathy. Annu Rev Med 1988;39:517-530.
3. Leenaerts PL, Hall BM, van Damme BJ, et al: Active Heymann nephritis in complement C6 deficient rats. Kidney Int 1995;47:1604-1614.
4. Penny MJ, Boyd RA, and Hall BM: Role of T cells in the mediation of Heymann nephritis: identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 1997;51:1059-1068.
5. Quiza CG, Leenaerts PL, Hall BM: The role of T cells in the mediation of glomerular injury in Heymann's nephritis. Int Immunol 1992;4:423-432.
6. Bonegio RGB, Fuhro R, Zhiyong W, et al: Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 2005;16:2063-2072.
7. Martel RR, Klicius J, Galet S: Inhibition of immune response by rapamycin, a new fungal antibiotic. Can J Physiol Pharmacol 1977;55:48-51.
8. Sengal NS: Rapamune ® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998;31:335-340.
9. Vasquez EM: Sirolimus: a new agent for prevention of renal allograft rejection. Am J Health Syst Pharm 2000;57:437-448.
10. Salant DJ, Quigg RJ, Cybulski AV: Heymann nephritis: mechanisms of renal injury. Kidney Int 1989;35:976-984.
11. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Vallera DA: Rapamycin inhibits the generation of graft-versus-host disease and graft-versus-leukemia- causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines. J Immunol 1998;160:5355-5365.
12. Edgington TS, Glassock RJ, Dixon FJ: Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med 1968;127:555-571.
13. Watson JI, Dixon FJ, Feldman JD: The effect of complete Freund's adjuvant on rat kidneys. Lab Invest 1965;14:1559-1567.
14. Zanetti M, Bellon B, Verroust P, Druet P: A search for circulating immune complex-like material during the course of autoimmune complex glomerulonephritis in Lewis and Brown Norway rats. Clin Exp Immunol 1980;42:86-94.
15. Heymann W, Hunter JLP, Hackel DB: Experimental autoimmune nephrosis in rats. J Immunol 1962;88:135-142.
16. Flueren GJ, Hoedemaker PJ: Triple drug treatment of autologous immune complex glomerulonephritis. Clin Exp Immunol 1980;41:218-224.
17. Tornroth T: The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis. Clin Exp Immunol 1990;79:266-272.
18. Catran DC: Effect of cyclosporin on active Heymann nephritis. Nephron 1988;48:142-148.
19. Matsukawa W, Hara S, Yoshida F, et al: Effects of new immunosuppressive agent, FK506, in rats with Heymann nephritis. J Lab Clin Med 1992;119:116-123.
20. Penny MJ, Boyd RA, and Hall BM: Mycophenolate mofetil prevent the induction of active Heymann nephritis: association with Th2 cytokine inhibition. J Am Soc Nephrol 1998;9:2272-2282.
21. Penny MJ, Boyd RA, Hall BM: Permanent CD8+ T cell depletion prevents proteinuria in active Heymann nephritis. J Exp Med 1998;188:1775-1784.
22. Ikeda E, Hikita N, Eto K, Mochizuki M: Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis. Jpn J Ophthalmol 1997;41:396-402.
23. Warner LM, Adams LM, Sehgal SN: Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. Arthritis Rheum 1999;37:289-297.
24. Carlson RP, Hartman DA, Ochalski SJ, et al: Sirolimus (rapamycin, Rapamune) and combination therapy with cyclosporin A in the rat developing adjuvant arthritis model: correlation with blood levels and the effects of different oral formulations. Inflamm Res 1998;47:339-344.
25. Fervenza FC, Fitzpatrick PM, Mertz J, et al: Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulonephrities. Nephrol Dial Transplant 2004;19:1288-1292.
26. Djukanovic LJ, Naumovic R: Posttransplantation immunosuppression; in Ležaić V, Djukanović LJ (eds): Kidney Transplantation. Belgrade, Institute for Textbooks and Educational Tools, 2004, vol 1, pp 111-143.
27. Diekmann F, Campistol JM: Conversion from calcineurin inhibitor to sirolimus in chronic allograft nephropathy: benefits and risks. Nephrol Dial Transplant 2006;21:562-568.
28. Morelon E, Kreis H: Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transpl Proc 2003:35(suppl 3A):52S-57S.
29. van den Akker JM, Wetzels JFM, Hoitsma AJ: Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. Kidney Int 2006;70:1355-1357.
30. Straathof-Galema L, Wetzels JF, Dijkman HB, et al: Sirolimus associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism. Am J Transplant 2006;6:429-433.
31. Kahan BD: Sirolimus; in Morris PJ (ed): Kidney Transplantation. Principles and Practice. Philadelphia, Saunders, 2001, pp 217-226.